The conference call did not provide any firm information regarding funding of the phase 3 trials.
The call indicated that Alchemia was reasonably sure one desired funding option for the phase three trials would be achieved and that the trials would commence late September or early Octobre. Alchemia also indicated minimising dilution of shareholder interests was high on their agenda.
positive step forward, page-9
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TSN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable